As of November 10, 2026, Rocket Pharmaceuticals Inc is a publicly traded company (Nasdaq: RCKT). The largest insider holding is Roderick Wong, a director and 10% owner, with 18,263,956 shares (16.6% of shares outstanding), per Form 4 of July 6, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, July 31, 2026).
Is this your company?
About to sign with, pay or invest in Rocket Pharmaceuticals Inc? See the free Snapshot first.
Free to see. No signup.
Is Rocket Pharmaceuticals Inc a real, registered company?
- Rocket Pharmaceuticals Inc files with the SEC under CIK 1281895 (its SEC filings).
- Its shares are listed under the ticker RCKT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in New York, New York, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Rocket Pharmaceuticals Inc in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Joseph Manhede, Principal Accounting Officer (Form 8-K filed 2026-06-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vanguard (filed 2026-07-31).
Who are Rocket Pharmaceuticals Inc's owners and officers?
Rocket Pharmaceuticals Inc: incorporated in Delaware; business address in New York, New York; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-30).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-30 | Vanguard Portfolio Management | 1.33% |
| Schedule 13G, 2026-07-31 | Vanguard Portfolio Management | 5.35% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-13 | Maverick Capital, LTD. | 2.3% |
| Schedule 13G/A, 2026-01-30 | The Vanguard Group | 7.89% |
| Schedule 13G/A, 2025-08-14 | Maverick Capital, LTD. | 7.8% |
Want the whole picture on Rocket Pharmaceuticals Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rocket Pharmaceuticals Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rocket Pharmaceuticals Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-30 | Joseph Manhede | Principal Accounting Officer | appointed | 2026-07-08 |
Which insiders own Rocket Pharmaceuticals Inc shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 18,263,956 shares (16.6% of shares outstanding), 75,499 held directly and 18,188,457 indirectly (Form 4, 2026-07-06).
- RTW Investments, a director and 10% owner: 18,236,124 shares (16.6% of shares outstanding), 47,667 held directly and 18,188,457 indirectly, on a joint filing (Form 4, 2025-09-23).
- , the chief executive: 1,462,832 shares (1.3% of shares outstanding), 1,056,594 held directly and 406,238 indirectly (Form 4, 2026-08-20).
- , a director: 1,036,846 shares (0.94% of shares outstanding), held indirectly through By Simran Investment Group (Form 4, 2025-07-18).
- Kinnari Patel: 573,628 shares (0.52% of shares outstanding), 441,927 held directly and 131,701 indirectly (Form 4, 2025-05-22).
Shares outstanding: 109,774,597 as of 2026-07-31, from the company's latest SEC cover page.
How much has Rocket Pharmaceuticals Inc raised?
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-06-12).
Keep reading
More on Rocket Pharmaceuticals Inc and the records around it.
Rocket Pharmaceuticals Inc elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- Maverick Capital, Ltd. also filed stake reports on 5 other companies: Infleqtion, Inc. (May 2026), Invivyd, Inc. (Feb 2026), Peabody Energy Corporation (Feb 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/rocket-pharmaceuticals